Progesterone: the ultimate endometrial tumor suppressor.

Area of Science:

• Reproductive Endocrinology and Oncology
• Molecular Biology of Hormone Action

Background:

• The uterine endometrium responds to steroid hormones like estrogen and progesterone via nuclear receptors.
• Estrogen promotes epithelial proliferation, while progesterone inhibits growth and induces differentiation.
• Progesterone's role as a tumor suppressor is evidenced by the low incidence of endometrial cancer in ovulating women.

Purpose of the Study:

• To review seminal research defining progesterone as a major endometrial tumor suppressor.
• To discuss progesterone-regulated genes, signaling pathways, and factors influencing progesterone receptor (PR) activity.
• To identify therapeutic targets for endometrial cancer based on progesterone-regulated pathways.

Main Methods:

• Review of established research findings on progesterone's effects on the endometrium.
• Analysis of molecular mechanisms underlying progesterone action through progesterone receptors (PRs).
• Identification of regulatory factors and signaling pathways involved in progesterone/PR activity.

Main Results:

• Progesterone acts as the primary endometrial tumor suppressor, counteracting estrogen-driven proliferation.
• Progesterone controls numerous genes and diverse signaling pathways critical for endometrial homeostasis.
• Multiple factors modulate progesterone and PR activity, influencing their tumor-suppressive functions.

Conclusions:

• Progesterone is a critical inhibitor of endometrial carcinogenesis.
• Elucidating progesterone-regulated pathways reveals key therapeutic strategies for endometrial cancer.
• Targeting progesterone signaling pathways offers promising avenues for endometrial cancer treatment.